Vista Therapeutics, Inc.
Doing business as Vista
- UEI
- GEBNUKLS8MC6
- CAGE
- 55QS7
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nanobiosensor analysis of antibodies against biomarker protein plant pathogen rathayibacter toxicus. | Central Program Planning Coordination and Support | $13,450 |
Quick answers
What is Vista Therapeutics, Inc.'s UEI?
Vista Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is GEBNUKLS8MC6.
What is Vista Therapeutics, Inc.'s CAGE code?
Vista Therapeutics, Inc.'s CAGE code is 55QS7.
What is Vista Therapeutics, Inc.'s primary NAICS code?
Vista Therapeutics, Inc.'s primary NAICS code is 541711 (Research and Development in Biotechnology).
Is Vista Therapeutics, Inc. registered in SAM.gov?
Vista Therapeutics, Inc.'s SAM.gov registration expired on August 30, 2018.
What is Vista Therapeutics, Inc.'s most recent federal award?
Vista Therapeutics, Inc.'s most recent federal contract award is Nanobiosensor analysis of antibodies against biomarker protein plant pathogen rathayibacter toxicus (AG32SCP170408), from Central Program Planning Coordination and Support, on September 5, 2017.
On GovTribe
See Vista Therapeutics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors